"Dermatitis, Exfoliative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)
Descriptor ID |
D003873
|
MeSH Number(s) |
C17.800.174.318 C17.800.815.318
|
Concept/Terms |
Dermatitis, Exfoliative- Dermatitis, Exfoliative
- Dermatitides, Exfoliative
- Exfoliative Dermatitides
- Exfoliative Dermatitis
- Dermatitis Exfoliativa
- Erythroderma
- Erythrodermas
|
Below are MeSH descriptors whose meaning is more general than "Dermatitis, Exfoliative".
Below are MeSH descriptors whose meaning is more specific than "Dermatitis, Exfoliative".
This graph shows the total number of publications written about "Dermatitis, Exfoliative" by people in this website by year, and whether "Dermatitis, Exfoliative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2017 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatitis, Exfoliative" by people in Profiles.
-
Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. 2020 May; 312(4):283-288.
-
The "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and S?zary syndrome. Int J Dermatol. 2018 01; 57(1):123-124.
-
The child with recalcitrant dermatitis: when to worry? Dermatol Clin. 2013 Apr; 31(2):223-8.
-
Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov; 47(5):672-84.
-
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002 Jan; 46(1):95-106.
-
Exfoliative dermatitis. Am Fam Physician. 1999 Feb 01; 59(3):625-30.
-
Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood. 1997 Jan 01; 89(1):32-40.
-
Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996 Oct; 35(4):573-9.
-
Cutaneous manifestations in chronic lymphocytic leukemia. J Dermatol Surg Oncol. 1984 Apr; 10(4):278-82.
-
Exfoliative dermatitis: presenting sign of internal malignancy. South Med J. 1979 Jun; 72(6):652-3.